Ieq Capital LLC Has $1.87 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Ieq Capital LLC raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 10.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,149 shares of the biotechnology company’s stock after purchasing an additional 298 shares during the period. Ieq Capital LLC’s holdings in Axon Enterprise were worth $1,872,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter worth approximately $200,000. Massachusetts Financial Services Co. MA purchased a new position in Axon Enterprise in the third quarter worth $120,553,000. Westfield Capital Management Co. LP grew its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Assenagon Asset Management S.A. increased its position in shares of Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the last quarter. Finally, Champlain Investment Partners LLC increased its position in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Trading Down 5.3 %

NASDAQ AXON opened at $513.22 on Monday. The stock has a market cap of $39.13 billion, a P/E ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99. The stock has a 50 day simple moving average of $619.94 and a two-hundred day simple moving average of $519.86. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Insider Activity at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now directly owns 24,259 shares in the company, valued at $15,518,239.71. The trade was a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 over the last quarter. Corporate insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of a number of research analyst reports. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Northland Securities lifted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a research report on Thursday. Finally, The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $561.31.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.